Suki Stock
HealthTechLooking to sell Suki stock or options?
Suki has developed a medical voice assistant designed to simplify clinical documentation and alleviate the administrative workload for healthcare professionals. This innovative platform leverages artificial intelligence and natural language processing to generate comprehensive clinical notes during or after patient consultations. By doing so, it enables doctors and surgeons to make better use of their time, mitigate burnout, and enhance both the quality of patient care and the precision of their medical records.
Qammer Bokhari, SV Pacific Ventures, Pankaj Patel, Epsilon Health, Gaingels, Andrew Deutsch, Social Capital, First Round Capital, Flare Capital Partners, Canal Pointe Capital, March Capital, Marc Benioff, Philips Ventures, Hedosophia, Venrock, Nathaniel Turner, InHealth Ventures, Breyer Capital, AI Venture Labs, Russell Farscht.
Our available services for this company
Management Team
Board Members
Suki’s stock FAQs
Suki is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Suki stock. Depending on Suki’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Suki stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Suki stock in two ways. First, Suki employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Suki stock. Note that all transactions in Suki shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Suki stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Suki stock. Typically, shares of private companies like Suki are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Oct 2024, Suki is reported to have closed an equity financing in which the investors valued the company at $283M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Suki shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Suki is not currently publicly traded, it does not have a ticker symbol.
Suki has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Suki is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Suki shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.
